Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Didem Saygin

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Seminars in Arthritis and Rheumatism|June 8, 2024
The impact of pain on daily activities in patients with idiopathic inflammatory myopathies: Report from the OMERACT myositis working groupDidem Saygin, Helene Alexanderson, Dana DiRenzo, et al.
Seminars in Arthritis and Rheumatism|August 19, 2024
Construct validity of PROMIS pain interference, fatigue, and physical function as patient-reported outcomes in adults with idiopathic inflammatory myopathies: An international study from the OMERACT myositis working groupEllen Romich, Didem Saygin, Dana DiRenzo, et al.
JCI Insight|August 18, 2017
Pulmonary arterial hypertension treatment with carvedilol for heart failure: a randomized controlled trialSamar Farha, Didem Saygin, Margaret M Park, et al.
Seminars in Arthritis and Rheumatism|November 21, 2022
Reliability and validity of PROMIS physical function, pain interference, and fatigue as patient reported outcome measures in adult idiopathic inflammatory myopathies: International study from the OMERACT myositis working groupDana DiRenzo, Didem Saygin, Ingrid de Groot, et al.
Clinical and Experimental Rheumatology|March 4, 2024
Performance of the 2017 EULAR/ACR Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a scoping reviewDidem Saygin, Stefanie Glaubitz, Rachel Zeng, et al.
Seminars in Arthritis and Rheumatism|February 10, 2024
Evolving and evaluating the OMERACT fellows program: insights and implications from OMERACT 2023 fellowsLara S Chapman, Ayano Kelly, Erin Balay-Dustrude, et al.
Rheumatology (Oxford, England)|March 17, 2023
Performance of the 2016 ACR-EULAR Myositis Response Criteria in adult dermatomyositis/polymyositis therapeutic trials and consensus profilesDidem Saygin, Hanna Kim, Christian Douglas, et al.
Rheumatology (Oxford, England)|April 24, 2025
Abatacept for the treatment of myositis-associated interstitial lung disease (ATtackMy-ILD)Rohit Aggarwal, Nantakarn Pongtarakulpanit, Daniel I Sullivan, et al.
Seminars in Arthritis and Rheumatism|April 25, 2026
A systematic approach to the consensus definitions and reliability of ultrasound in idiopathic inflammatory myopathies; Preliminary data by the OMERACT ultrasound in myositis working groupShereen Paramalingam, Jemima Albayda, Nens van Alfen, et al.
Rheumatology (Oxford, England)|September 2, 2024
Associations between 6-minute walk distance and physiologic measures and clinical outcomes in myositis-associated interstitial lung diseaseSangmee Sharon Bae, Daniela Markovic, Didem Saygin, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Seminars in Arthritis and Rheumatism|June 8, 2024
The impact of pain on daily activities in patients with idiopathic inflammatory myopathies: Report from the OMERACT myositis working groupDidem Saygin, Helene Alexanderson, Dana DiRenzo, et al.
Seminars in Arthritis and Rheumatism|August 19, 2024
Construct validity of PROMIS pain interference, fatigue, and physical function as patient-reported outcomes in adults with idiopathic inflammatory myopathies: An international study from the OMERACT myositis working groupEllen Romich, Didem Saygin, Dana DiRenzo, et al.
JCI Insight|August 18, 2017
Pulmonary arterial hypertension treatment with carvedilol for heart failure: a randomized controlled trialSamar Farha, Didem Saygin, Margaret M Park, et al.
Seminars in Arthritis and Rheumatism|November 21, 2022
Reliability and validity of PROMIS physical function, pain interference, and fatigue as patient reported outcome measures in adult idiopathic inflammatory myopathies: International study from the OMERACT myositis working groupDana DiRenzo, Didem Saygin, Ingrid de Groot, et al.
Clinical and Experimental Rheumatology|March 4, 2024
Performance of the 2017 EULAR/ACR Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a scoping reviewDidem Saygin, Stefanie Glaubitz, Rachel Zeng, et al.
Seminars in Arthritis and Rheumatism|February 10, 2024
Evolving and evaluating the OMERACT fellows program: insights and implications from OMERACT 2023 fellowsLara S Chapman, Ayano Kelly, Erin Balay-Dustrude, et al.
Rheumatology (Oxford, England)|March 17, 2023
Performance of the 2016 ACR-EULAR Myositis Response Criteria in adult dermatomyositis/polymyositis therapeutic trials and consensus profilesDidem Saygin, Hanna Kim, Christian Douglas, et al.
Rheumatology (Oxford, England)|April 24, 2025
Abatacept for the treatment of myositis-associated interstitial lung disease (ATtackMy-ILD)Rohit Aggarwal, Nantakarn Pongtarakulpanit, Daniel I Sullivan, et al.
Seminars in Arthritis and Rheumatism|April 25, 2026
A systematic approach to the consensus definitions and reliability of ultrasound in idiopathic inflammatory myopathies; Preliminary data by the OMERACT ultrasound in myositis working groupShereen Paramalingam, Jemima Albayda, Nens van Alfen, et al.
Rheumatology (Oxford, England)|September 2, 2024
Associations between 6-minute walk distance and physiologic measures and clinical outcomes in myositis-associated interstitial lung diseaseSangmee Sharon Bae, Daniela Markovic, Didem Saygin, et al.
Pageof 7